دورية أكاديمية
أعرض في EDS

Respiratory virus circulation during the first year of the COVID-19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort.

التفاصيل البيبلوغرافية
العنوان: Respiratory virus circulation during the first year of the COVID-19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort.
المؤلفون: Fine SR; Department of Epidemiology University of Michigan Ann Arbor Michigan USA., Bazzi LA; Department of Epidemiology University of Michigan Ann Arbor Michigan USA.; Present address: Northwestern University Evanston Illinois USA.; Present address: Northwestern University Evanston Illinois USA., Callear AP; Department of Epidemiology University of Michigan Ann Arbor Michigan USA., Petrie JG; Department of Epidemiology University of Michigan Ann Arbor Michigan USA.; Present address: Marshfield Clinic Research Institute Marshfield Wisconsin USA.; Present address: Marshfield Clinic Research Institute Marshfield Wisconsin USA., Malosh RE; Department of Epidemiology University of Michigan Ann Arbor Michigan USA.; Present address: Michigan Department of Health and Human Services Lansing Michigan USA.; Present address: Michigan Department of Health and Human Services Lansing Michigan USA., Foster-Tucker JE; Department of Epidemiology University of Michigan Ann Arbor Michigan USA., Smith M; Department of Epidemiology University of Michigan Ann Arbor Michigan USA., Ibiebele J; Department of Epidemiology University of Michigan Ann Arbor Michigan USA., McDermott A; Vaccine Research Center National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda Maryland USA., Rolfes MA; Influenza Division Centers for Disease Control and Prevention Atlanta Georgia USA., Monto AS; Department of Epidemiology University of Michigan Ann Arbor Michigan USA., Martin ET; Department of Epidemiology University of Michigan Ann Arbor Michigan USA.
المصدر: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Mar 01; Vol. 17 (3), pp. e13106. Date of Electronic Publication: 2023 Mar 01 (Print Publication: 2023).
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: eCollection Cited Medium: Internet ISSN: 1750-2659 (Electronic) Linking ISSN: 17502640 NLM ISO Abbreviation: Influenza Other Respir Viruses Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Oxford, UK : Wiley, c2007-
مواضيع طبية MeSH: Influenza Vaccines* , Influenza, Human* , COVID-19*, Humans ; Pandemics ; SARS-CoV-2 ; Rhinovirus
مستخلص: Background: The annual reappearance of respiratory viruses has been recognized for decades. COVID-19 mitigation measures taken during the pandemic were targeted at respiratory transmission and broadly impacted the burden of acute respiratory illnesses (ARIs).
Methods: We used the longitudinal Household Influenza Vaccine Evaluation (HIVE) cohort in southeast Michigan to characterize the circulation of respiratory viruses from March 1, 2020, to June 30, 2021, using RT-PCR of respiratory specimens collected at illness onset. Participants were surveyed twice during the study period, and SARS-CoV-2 antibodies were measured in serum by electrochemiluminescence immunoassay. Incidence rates of ARI reports and virus detections were compared between the study period and a preceding pre-pandemic period of similar duration.
Results: Overall, 437 participants reported a total of 772 ARIs; 42.6% had respiratory viruses detected. Rhinoviruses were the most frequent virus, but seasonal coronaviruses, excluding SARS-CoV-2, were also common. Illness reports and percent positivity were lowest from May to August 2020, when mitigation measures were most stringent. Seropositivity for SARS-CoV-2 was 5.3% in summer 2020 and increased to 11.3% in spring 2021. The incidence rate of total reported ARIs for the study period was 50% lower (95% CI: 0.5, 0.6; p  < 0.001) than the incidence rate from a pre-pandemic comparison period (March 1, 2016, to June 30, 2017).
Conclusions: The burden of ARI in the HIVE cohort during the COVID-19 pandemic fluctuated, with declines occurring concurrently with the widespread use of public health measures. Rhinovirus and seasonal coronaviruses continued to circulate even when influenza and SARS-CoV-2 circulation was low.
Competing Interests: ETM reports grant funding from Merck outside of the submitted work.
(© 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.)
التعليقات: Update of: medRxiv. 2022 Dec 09;:. (PMID: 36523413)
References: PLoS One. 2009 Aug 24;4(8):e6671. (PMID: 19701458)
Int J Epidemiol. 2019 Aug 1;48(4):1040-1040g. (PMID: 31038700)
J Clin Microbiol. 1997 Nov;35(11):2864-8. (PMID: 9350748)
J Virol Methods. 2020 Sep;283:113919. (PMID: 32554043)
Paediatr Respir Rev. 2003 Jun;4(2):105-11. (PMID: 12758047)
PLoS Comput Biol. 2010 Jan 29;6(1):e1000656. (PMID: 20126529)
Am J Public Health. 1982 Nov;72(11):1280-3. (PMID: 7125031)
J Infect Dis. 2021 Jul 2;224(1):49-59. (PMID: 33755731)
Nature. 2006 Jul 27;442(7101):448-52. (PMID: 16642006)
Clin Infect Dis. 2021 Oct 5;73(7):1248-1256. (PMID: 33949666)
Clin Infect Dis. 2021 Dec 6;73(11):e4384-e4391. (PMID: 33095882)
Influenza Other Respir Viruses. 2021 Mar;15(2):227-234. (PMID: 33107200)
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30547-30553. (PMID: 33168723)
BMC Public Health. 2021 Jun 21;21(1):1178. (PMID: 34154549)
Environ Res. 2021 Mar;194:110716. (PMID: 33421429)
Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S58-64. (PMID: 14730271)
Nat Commun. 2022 May 24;13(1):2884. (PMID: 35610217)
J Infect Dis. 2014 Dec 1;210(11):1792-9. (PMID: 24907381)
Pediatrics. 2021 Aug;148(2):. (PMID: 33986150)
Nat Rev Dis Primers. 2018 Jun 28;4(1):3. (PMID: 29955068)
Influenza Other Respir Viruses. 2022 May;16(3):521-531. (PMID: 34821476)
J Clin Microbiol. 2021 Jun 18;59(7):e0043121. (PMID: 33903168)
Influenza Other Respir Viruses. 2021 Nov;15(6):804-812. (PMID: 34219389)
Emerg Infect Dis. 2021 Feb;27(2):641-643. (PMID: 33263515)
J Infect Dis. 2007 Mar 15;195(6):765-6. (PMID: 17299703)
PLoS Pathog. 2018 Feb 15;14(2):e1006770. (PMID: 29447284)
BMC Med. 2021 Feb 5;19(1):40. (PMID: 33541353)
Pediatr Infect Dis J. 2020 Dec;39(12):e423-e427. (PMID: 32773660)
J Infect Dis. 2018 Jul 2;218(3):406-417. (PMID: 29746640)
Am J Respir Crit Care Med. 2012 Jun 15;185(12):1275-9. (PMID: 22366048)
J Pediatr. 2021 Jul;234:164-171.e2. (PMID: 33774057)
J Antimicrob Chemother. 1999 Nov;44 Suppl B:3-9. (PMID: 10877456)
Proc Natl Acad Sci U S A. 2019 Dec 26;116(52):27142-27150. (PMID: 31843887)
معلومات مُعتمدة: 75N93021C00015 United States AI NIAID NIH HHS; U01 IP001034 United States IP NCIRD CDC HHS; U01IP001034 United States ACL ACL HHS
فهرسة مساهمة: Keywords: COVID‐19; household cohort; influenza; respiratory virus; serological surveillance
المشرفين على المادة: 0 (Influenza Vaccines)
تواريخ الأحداث: Date Created: 20230306 Date Completed: 20230307 Latest Revision: 20240503
رمز التحديث: 20240503
مُعرف محوري في PubMed: PMC9975790
DOI: 10.1111/irv.13106
PMID: 36875204
قاعدة البيانات: MEDLINE
الوصف
تدمد:1750-2659
DOI:10.1111/irv.13106